Heart Beat – February 2023

 New Drug Pulls Heart Failure Patients Back From the Brink The dual SGLT-2 inhibitor sotagliflozin reduced deaths within 30 to 90 days in patients with diabetes and worsening heart failure, researchers reported at the American Heart Association Scientific Sessions in November 2022. This finding is significant, because one in four heart-failure patients are readmitted to […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access